Latest Breaking News On - Status epilepticus - Page 5 : comparemela.com

SciSparc (SPRC) Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy

SciSparc (SPRC) Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adi zuloff shaniScisparc ltdChaim sheba medical centerSheba fund for health servicesCompany or scisparcStatus epilepticusSheba fundHealth servicesChief technology officer

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

UCSF Perspective Article Says New Ruling May Result in Increased Risk of Deaths, Disability.

United statesSan franciscoSara lahueRiley boveEmily hendersonUniversity of californiaDepartment of neurologyWeill institute for neurosciencesArticle says new ruling may resultIncreased riskStudy corresponding authorWeill instituteBirth defectsMultiple sclerosisMyasthenia gravisStatus epilepticus

CROSSJECT: Agreement with BARDA on ZENEO® Midazolam

Press Release Agreement with BARDA on ZENEO® Midazolam BARDA places a firm order of $60m to CROSSJECT for initial procurement of ZENEO® Midazolam.

United statesPatrick alexandreUs department of healthHuman servicesBiomedical advanced researchDevelopment authorityStrategic national stockpileUs strategic nationalOffice of theStrategic nationalEmergency medical servicesCrossject havingSaving livesStatus epilepticusEmergency use authorizationNew drug application

CROSSJECT: Agreement with BARDA on ZENEO Midazolam Seite 1

18.06.2022 - Press Release Agreement with BARDA on ZENEO Midazolam BARDA places a firm order of $60m to CROSSJECT for initial procurement of ZENEO Midazolam into the U.S. Strategic National Stockpile1 as soon as FDA Authorization is obtainedBARDA also . Seite 1

United statesPatrick alexandreCrossject havingzeneomidazolamavailabletoUs strategic nationalSaving livesStatus epilepticusEmergency use authorizationNew drug application

Marinus Pharma (MRNS) Resumes Phase 3 RAISE Trial in Status Epilepticus

Marinus Pharma (MRNS) Resumes Phase 3 RAISE Trial in Status Epilepticus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sasha damouni ellisUs department of healthHuman servicesBiomedical advanced researchCorporate affairs investor relationsDrug administrationData monitoring committeeDevelopment authorityExchange commissionMarinus pharmaceuticalsMarinus pharmaceuticals incOffice of theRandomized therapyStatus epilepticusAssistant secretaryPrivate securities litigation reform act